• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS ENDOVASCULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS ENDOVASCULAR STENT GRAFT Back to Search Results
Model Number FEL10120
Device Problems Positioning Failure (1158); Difficult to Remove (1528); Misfire (2532); Positioning Problem (3009)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/17/2018
Event Type  malfunction  
Manufacturer Narrative
No medical records and no medical images were provided to the manufacturer.The lot number for the device was provided.The device history records are currently under review.The device was returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that after multiple attempts, the endovascular stent graft allegedly would not deploy in the left common iliac artery via a right common femoral artery access site.It was further reported that there was some difficulty advancing the delivery system to and retracting the delivery system from the target lesion.Reportedly, another stent was used to complete the procedure.There was no reported patient injury.
 
Event Description
It was reported that after multiple attempts, the endovascular stent graft allegedly would not deploy in the left common iliac artery via a right common femoral artery access site.It was further reported that there was some difficulty advancing the delivery system to and retracting the delivery system from the target lesion.Reportedly, another stent was used to complete the procedure.There was no reported patient injury.
 
Manufacturer Narrative
Manufacturing review: based on the information available and the investigation performed, there is no indication that the product failed to meet its specification prior to shipment.The lot records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.The review shows that no remarkable incidents occurred during the manufacturing process.No relevant manufacturing process changes were implemented, that could have led to the event reported.Investigation summary: on the basis of the returned stent graft delivery system, the alleged deployment issue could be confirmed.The outer sheath was found to be elongated which indicated that increased friction affected the delivery system during attempt of stent graft deployment and subsequently resulted in a partial stent graft deployment.The reported difficulties to advance and to retract the delivery system to the target lesion could not be reproduced.No indication was found for manufacturing related issues.Based on the information available and the evaluation of the sample returned, a definite root cause for the reported event could not be determined.Labeling review: in reviewing the current labeling it was found that the instructions for use (ifu) sufficiently address the potential risk.The ifu states: "if unusual resistance or high deployment force is encountered during stent graft deployment, abort the procedure, remove the delivery system and use an alternative device." furthermore, the ifu states: "prior to loading the endovascular system over a guide wire, both ports must be flushed with sterile saline (¿).Flushing these lumens will also facilitate stent graft deployment." regarding treatment of aneurysms the ifu states: "the safety and effectiveness of the device when placed across an aneurysm or a pseudoaneurysm has not been evaluated." (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS ENDOVASCULAR STENT GRAFT
Type of Device
ENDOVASCULAR STENT GRAFT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key7895617
MDR Text Key120966549
Report Number9681442-2018-00173
Device Sequence Number1
Product Code PFV
UDI-Device Identifier04049519008271
UDI-Public(01)04049519008271
Combination Product (y/n)N
PMA/PMN Number
P130029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 11/01/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/20/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/13/2020
Device Model NumberFEL10120
Device Catalogue NumberFEL10120
Device Lot NumberANBR1726
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/12/2018
Date Manufacturer Received10/22/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age72 YR
Patient Weight76
-
-